Healthcare >> CEO Interviews >> June 13, 2003
TWST: Let's start with a brief historical sketch of Cobra and tell us DAVID THATCHER, PhD, is Chief Executive of Cobra Biomanufacturing Plc.
Mr. Thatcher was trained as a Protein Chemist at the Universities of
Newcastle upon Tyne and Edinburgh. In 1981 he moved to Biogen SA in
Geneva where he worked on the isolation of recombinant cytokines. In
1985 he became Director of Process Development of Biogen Inc.,
Cambridge, Massachusetts, where he was responsible for the development
of large-scale processes for the production of gamma interferon, GM-CSF
and several other products. Profile
how you see the company positioned.
Mr. Thatcher: Cobra is a supplier of manufacturing solutions to the